SCHEMBL13256304

SCHEMBL13256304

O=C(Nc1nc2[nH]nc(-c3ccccc3)c2s1)c1cccs1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 12/20 0.65
KMT2A Q03164 8/20 0.65
MEN1 O00255 6/20 0.65
LMNA P02545 6/20 0.65
NPSR1 Q6W5P4 4/20 0.65
PKM P14618 3/20 0.65
NPC1 O15118 10/20 0.56
HTT P42858 5/20 0.56
TP53 P04637 3/20 0.56
MAPK1 P28482 3/20 0.56
HSD17B10 Q99714 3/20 0.56
ALOX15 P16050 2/20 0.56
TSHR P16473 2/20 0.56
MAPT P10636 4/20 0.55
SMN1; SMN2 Q16637 4/20 0.55
GFER P55789 1/20 0.55
CASP3 P42574 2/20 0.54
SENP8 Q96LD8 2/20 0.54
SENP7 Q9BQF6 2/20 0.54
SENP6 Q9GZR1 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13256167 0.84 RAB9A (0.51) RAB9AKMT2AMEN1LMNANPSR1
SCHEMBL3500537 0.82 PARP1 (0.54) RAB9AKMT2ALMNANPSR1NPC1
SCHEMBL13256299 0.81 SMN1; SMN2 (0.60) RAB9AKMT2AMEN1LMNANPSR1
SCHEMBL13256166 0.80 ALDH1A1 (0.53) RAB9AKMT2AMEN1LMNANPC1
SCHEMBL13256284 0.80 F2 (0.54) RAB9AKMT2AMEN1LMNAPKM
SCHEMBL3500983 0.80 MAPT (0.61) RAB9AKMT2AMEN1LMNAPKM
SCHEMBL13256296 0.78 HPGD (0.66) RAB9AKMT2AMEN1NPSR1PKM
SCHEMBL13256182 0.77 ADORA3 (0.46) RAB9AKMT2AMEN1LMNANPSR1
SCHEMBL13256286 0.77 HDAC1 (0.46) RAB9AKMT2AMEN1NPC1HSD17B10
SCHEMBL13256173 0.76 PTGDR2 (0.61) RAB9AKMT2AMEN1LMNANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100179190-A1 BICYCLIC PYRAZOLO PROTEIN KINASE MODULATORS SGX PHARMACEUTICALS, INC. (US) 2010-07-15 US disclosed
US-20100179190-A1 BICYCLIC PYRAZOLO PROTEIN KINASE MODULATORS SGX PHARMACEUTICALS, INC. (US) 2010-07-15 US disclosed
US-7473783-B2 Bicyclic pyrazolo protein kinase modulators SGX PHARMACEUTICALS, INC. (US) 2009-01-06 US disclosed
US-7473783-B2 Bicyclic pyrazolo protein kinase modulators SGX PHARMACEUTICALS, INC. (US) 2009-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100179190-A1 BICYCLIC PYRAZOLO PROTEIN KINASE MODULATORS MAP3K20, MAP4K2, MAP4K3 RAB9A 1601/4885KMT2A 1583/4885MEN1 4093/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.